At 2012 ASCO Dr. Vij, presented data showing pomalidomide works in lenalidomide and Bort refractory patients, even those who have failed SCT.
POM, given at 4 mg/day on days 1–21 of each 28-day cycle in combination with LoDEX, 40 mg/week, is effective in pts with RRMM refractory to LEN, BORT, or both, and including those with prior transplant. These results suggest a lack of cross-resistance between POM and LEN, and confirm activity not only in BORT-refractory pts but also those for whom transplant has failed.
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=114&abstractID=100148
Forums
2 posts
• Page 1 of 1
Return to Treatments & Side Effects
